Protagonist Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $59M | 1.3M | 45.00 |
| 2024-06-30 | $42M | 1.2M | 34.66 |
| 2024-03-31 | $24M | 819k | 28.93 |
| 2023-12-31 | $19M | 824k | 22.93 |
| 2023-09-30 | $14M | 832k | 16.68 |
| 2023-06-30 | $23M | 832k | 27.62 |
| 2023-03-31 | $9.6M | 415k | 23.00 |
| 2022-03-31 | $7.1M | 301k | 23.68 |
| 2021-12-31 | $13M | 377k | 34.20 |
| 2021-09-30 | $8.7M | 492k | 17.72 |
| 2021-06-30 | $44M | 986k | 44.88 |
| 2021-03-31 | $24M | 914k | 25.90 |
| 2020-12-31 | $17M | 845k | 20.16 |
| 2020-09-30 | $12M | 586k | 19.55 |
| 2020-06-30 | $13M | 748k | 17.66 |
| 2020-03-31 | $301k | 43k | 7.06 |
| 2019-12-31 | $300k | 43k | 7.06 |
| 2019-09-30 | $329k | 27k | 12.02 |
| 2019-06-30 | $236k | 20k | 12.11 |
| 2019-03-31 | $150k | 12k | 12.61 |
| 2018-12-31 | $142k | 21k | 6.73 |
| 2018-09-30 | $170k | 17k | 10.30 |
| 2018-06-30 | $111k | 17k | 6.73 |
| 2018-03-31 | $142k | 17k | 8.58 |
| 2017-12-31 | $204k | 9.8k | 20.77 |